CeriBell, Inc. (CBLL) vs Janux Therapeutics, Inc. (JANX)
A side-by-side comparison of CeriBell, Inc. and Janux Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CBLL
CeriBell, Inc.
$24.61HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
JANX
Janux Therapeutics, Inc.
$17.20HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — CBLL vs JANX
growth of $100 · dividends reinvested · last 2yCBLL -0.6% (-0.3%/yr)JANX -65.0% (-40.8%/yr)CBLL compounded faster over this window
CBLL JANX
CBLL vs JANX: by the numbers
- •JANX is the larger company ($1.05B vs $934M market cap).
- •Both run net losses; CBLL's is the smaller (-64.73% vs -321.81% net margin).
Metrics side by side
Valuation
| Metric | CBLL | JANX |
|---|---|---|
| P/S ratio | 9.16 | 32.90 |
| P/B ratio | 7.28 | 1.13 |
Profitability
| Metric | CBLL | JANX |
|---|---|---|
| Gross margin | 88.90% | 79.71% |
| Operating margin | -68.62% | -1576.67% |
| Net margin | -64.73% | -321.81% |
| ROE | -51.43% | -11.06% |
| ROIC | -46.54% | -15.15% |
Growth (annualized)
| Metric | CBLL | JANX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 105.89% |
| Total return CAGR (5Y) | N/A | -6.45% |
Go deeper
Dig into the metrics
CeriBell ROEJanux Therapeutics ROECeriBell operating marginJanux Therapeutics operating marginCeriBell revenue growthJanux Therapeutics revenue growthCeriBell free cash flowJanux Therapeutics free cash flow
CeriBell & Janux Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.